why choose us

First received: October 12, 2022

Clinical Trial: TArgeting Type 1 Diabetes Using POLyamines (TADPOL)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Type 1 Diabetes

Study Type: INTERVENTIONAL


Official Title: TArgeting Type 1 Diabetes Using POLyamines (TADPOL): A Randomized, Double-Masked, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of Difluoromethylornithine (DFMO) to Preserve Ins

Brief Summary: The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D).The main question[s] it aims to answer are:Does it reduce stress on the cells that make insulin?Does it preserve what is left of the body's insulin production?Participants will take either DFMO or a placebo (looks like DFMO but has no active ingredients) two times a day for about 6 months.Participants will have 6 in person visits and 1 phone visit over a period of 12 months.Visits will include blood draws…

Read more